SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
Europe - FRA:56S1 - FR0013154002 - Common Stock
169.7 EUR
-5 (-2.86%)
We assign a fundamental rating of 4 out of 10 to 56S1. 56S1 was compared to 18 industry peers in the Life Sciences Tools & Services industry. 56S1 has only an average score on both its financial health and profitability. 56S1 is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year 56S1 was profitable.
56S1 had a positive operating cash flow in the past year.
56S1 had positive earnings in each of the past 5 years.
Each year in the past 5 years 56S1 had a positive operating cash flow.
1.2 Ratios
56S1's Return On Assets of 2.71% is on the low side compared to the rest of the industry. 56S1 is outperformed by 66.67% of its industry peers.
With a Return On Equity value of 5.63%, 56S1 is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
56S1's Return On Invested Capital of 4.60% is on the low side compared to the rest of the industry. 56S1 is outperformed by 61.11% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 56S1 is above the industry average of 7.14%.
The last Return On Invested Capital (4.60%) for 56S1 is well below the 3 year average (10.41%), which needs to be investigated, but indicates that 56S1 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| ROIC | 4.6% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
56S1's Profit Margin of 7.78% is in line compared to the rest of the industry. 56S1 outperforms 55.56% of its industry peers.
In the last couple of years the Profit Margin of 56S1 has declined.
With a Operating Margin value of 14.71%, 56S1 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of 56S1 has declined.
56S1 has a Gross Margin of 44.63%. This is in the better half of the industry: 56S1 outperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of 56S1 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.71% | ||
| PM (TTM) | 7.78% | ||
| GM | 44.63% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 56S1 is still creating some value.
56S1 has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, 56S1 has more shares outstanding
56S1 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.62 indicates that 56S1 is not in any danger for bankruptcy at the moment.
The Altman-Z score of 56S1 (3.62) is better than 72.22% of its industry peers.
56S1 has a debt to FCF ratio of 5.98. This is a neutral value as 56S1 would need 5.98 years to pay back of all of its debts.
56S1 has a Debt to FCF ratio (5.98) which is in line with its industry peers.
A Debt/Equity ratio of 0.71 indicates that 56S1 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.71, 56S1 is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.98 | ||
| Altman-Z | 3.62 |
ROIC/WACC0.56
WACC8.15%
2.3 Liquidity
A Current Ratio of 1.91 indicates that 56S1 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.91, 56S1 is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
A Quick Ratio of 1.18 indicates that 56S1 should not have too much problems paying its short term obligations.
The Quick ratio of 56S1 (1.18) is worse than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.91% over the past year.
The Earnings Per Share has been growing slightly by 4.19% on average over the past years.
56S1 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.44%.
The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
3.2 Future
The Earnings Per Share is expected to grow by 22.34% on average over the next years. This is a very strong growth
Based on estimates for the next years, 56S1 will show a quite strong growth in Revenue. The Revenue will grow by 10.54% on average per year.
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.34%
Revenue Next Year10.5%
Revenue Next 2Y10.34%
Revenue Next 3Y10.36%
Revenue Next 5Y10.54%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 41.09, the valuation of 56S1 can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of 56S1 indicates a slightly more expensive valuation: 56S1 is more expensive than 77.78% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, 56S1 is valued quite expensively.
56S1 is valuated quite expensively with a Price/Forward Earnings ratio of 31.62.
Based on the Price/Forward Earnings ratio, 56S1 is valued a bit more expensive than 72.22% of the companies in the same industry.
56S1 is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.09 | ||
| Fwd PE | 31.62 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 56S1 is valued a bit more expensive than 77.78% of the companies in the same industry.
61.11% of the companies in the same industry are cheaper than 56S1, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.27 | ||
| EV/EBITDA | 25.33 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 56S1's earnings are expected to grow with 23.30% in the coming years.
PEG (NY)1.49
PEG (5Y)9.8
EPS Next 2Y23.83%
EPS Next 3Y23.3%
5. Dividend
5.1 Amount
56S1 has a yearly dividend return of 0.41%, which is pretty low.
Compared to an average industry Dividend Yield of 0.73, 56S1 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, 56S1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
5.2 History
The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
29.77% of the earnings are spent on dividend by 56S1. This is a low number and sustainable payout ratio.
56S1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP29.77%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
FRA:56S1 (9/12/2025, 7:00:00 PM)
169.7
-5 (-2.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.52B
Analysts81.11
Price Target239.46 (41.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.41% |
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP29.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.2%
Min EPS beat(2)10.22%
Max EPS beat(2)22.18%
EPS beat(4)3
Avg EPS beat(4)8.6%
Min EPS beat(4)-5.62%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)3
Avg EPS beat(12)-13.27%
EPS beat(16)5
Avg EPS beat(16)-12.35%
Revenue beat(2)2
Avg Revenue beat(2)1.91%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.47%
Revenue beat(16)8
Avg Revenue beat(16)12%
PT rev (1m)-0.47%
PT rev (3m)-3.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)2.93%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)4.7%
Revenue NQ rev (3m)3.71%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)1.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.09 | ||
| Fwd PE | 31.62 | ||
| P/S | 5.7 | ||
| P/FCF | 33.27 | ||
| P/OCF | 20.96 | ||
| P/B | 4.13 | ||
| P/tB | N/A | ||
| EV/EBITDA | 25.33 |
EPS(TTM)4.13
EY2.43%
EPS(NY)5.37
Fwd EY3.16%
FCF(TTM)5.1
FCFY3.01%
OCF(TTM)8.1
OCFY4.77%
SpS29.76
BVpS41.13
TBVpS-4.66
PEG (NY)1.49
PEG (5Y)9.8
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| ROCE | 5.78% | ||
| ROIC | 4.6% | ||
| ROICexc | 5.12% | ||
| ROICexgc | 15.67% | ||
| OM | 14.71% | ||
| PM (TTM) | 7.78% | ||
| GM | 44.63% | ||
| FCFM | 17.14% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.98 | ||
| Debt/EBITDA | 3.84 | ||
| Cap/Depr | 93.43% | ||
| Cap/Sales | 10.07% | ||
| Interest Coverage | 2.82 | ||
| Cash Conversion | 106.77% | ||
| Profit Quality | 220.28% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.62 |
F-Score7
WACC8.15%
ROIC/WACC0.56
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.34%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year10.5%
Revenue Next 2Y10.34%
Revenue Next 3Y10.36%
Revenue Next 5Y10.54%
EBIT growth 1Y7.47%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y27.81%
FCF growth 1Y202.01%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y16.41%
OCF growth 3Y5.11%
OCF growth 5Y21.32%